Q3 2020 13F Holders as of 9/30/2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
175M
-
Number of holders
-
722
-
Total 13F shares, excl. options
-
75.5M
-
Shares change
-
+4.07M
-
Total reported value, excl. options
-
$16.5B
-
Value change
-
+$918M
-
Put/Call ratio
-
1.2
-
Number of buys
-
439
-
Number of sells
-
-270
-
Price
-
$219.24
Significant Holders of Teladoc Health, Inc. - Common Stock (TDOC) as of Q3 2020
854 filings reported holding TDOC - Teladoc Health, Inc. - Common Stock as of Q3 2020.
Teladoc Health, Inc. - Common Stock (TDOC) has 722 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 75.5M shares
of 175M outstanding shares and own 43.03% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (7.21M shares), BAILLIE GIFFORD & CO (6.24M shares), BlackRock Inc. (6.14M shares), JENNISON ASSOCIATES LLC (5.96M shares), Capital World Investors (2.69M shares), BANK OF AMERICA CORP /DE/ (2.3M shares), ARK Investment Management LLC (2.01M shares), JPMORGAN CHASE & CO (1.88M shares), STATE STREET CORP (1.5M shares), and Discovery Value Fund (1.44M shares).
This table shows the top 722 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.